CANTARGIA ABCANTARGIA ABCANTARGIA AB

CANTARGIA AB

No trades
See on Supercharts

CANTA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. It focuses on the development of CAN04 for the treatment of non-small cell lung cancer and pancreatic cancer. The company was founded by Thoas Michael Fioretos, Kjell Torsten Sjostrom, and Marcus Jaras on October 26, 2009 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
CANTA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company